Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Enterprise Value

Adverum Biotechnlgs Enterprise Value Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Enterprise Value from 2014 to 2020.
  • Adverum Biotechnlgs Enterprise Value for the quarter ending September 09, 2020 was $956m a -4.58% decrease of -44m year over year
  • Adverum Biotechnlgs Enterprise Value for the last 12 months ending September 09, 2020 was $956m a -4.58% decrease of -44m year over year
  • Adverum Biotechnlgs Annual Enterprise Value for 2020 was $956m a -4.58% decrease of -44m from 2019
  • Adverum Biotechnlgs Annual Enterprise Value for 2020 was $1,000m a -0.19% decrease of -2m from 2019
  • Adverum Biotechnlgs Annual Enterprise Value for 2020 was $1,002m a 0.19% increase of 2m from 2019
Other Valuation Metrics:
  • Adverum Biotechnlgs Market Cap for the quarter ending March 03, 2018 was $361m a 70.28% increase of 253m year over year
  • Adverum Biotechnlgs Price / Book for the quarter ending March 03, 2018 was 1.54 a 65.62% increase of 1.01 year over year
View Chart On Koyfin

Quarterly ADVM Enterprise Value Data

09/2020$956m
09/2020$1,000m
09/2020$1,002m
09/2020$1,000m
09/2020$987m
09/2020$908m
09/2020$878m
09/2020$911m
09/2020$890m
09/2020$881m

Annual ADVM Enterprise Value Data

2020$956m
2020$1,000m
2020$1,002m
2020$1,000m
2020$987m
2020$908m
2020$878m
2020$911m
2020$890m
2020$881m